Logo-apb
Adv Pharm Bull. 2025;15(1): 143-153. doi: 10.34172/apb.43859

Original Article

Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma

Maryam Samareh-Salavatipour 1 ORCID, Shirin Tavakoli 1 ORCID, Maryam Barkhordar 2, Iman Seyhoun 1 * , Nasim Vousooghi 1, Mohammad Vaezi 2, Afshin Ghaderi 3, Tahereh Bakhtiari 4, Ardeshir Ghavamzadeh 2, Javad Verdi 1 * ORCID, Mohammad Ahmadvand 2 * ORCID

Cited by CrossRef: